Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$443,200
-$46,406 QoQ
Shares Held
3,508
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,434
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. GILD ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,200 | 3,508 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $489,606 | 3,513 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $430,571 | 3,508 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $389,055 | 3,505 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $388,045 | 3,500 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $392,175 | 3,500 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $321,909 | 3,485 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $289,667 | 3,455 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $235,332 | 3,430 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $250,515 | 3,420 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $276,244 | 3,410 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $255,545 | 3,410 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $262,808 | 3,410 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $282,927 | 3,410 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $292,748 | 3,410 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $659,219 | 10,686 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $653,764 | 10,577 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $626,008 | 10,530 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $798,274 | 10,994 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $719,594 | 10,302 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $667,184 | 9,689 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $434,701 | 6,726 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $428,735 | 7,359 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $428,365 | 6,779 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $512,343 | 6,659 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $484,071 | 6,475 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||